Impact Biomedical Quote - IBO | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
AMEX
Impact Biomedical Inc (IBO) Share Price

Impact Biomedical Inc (IBO)

2.08

-0.07

(-3.26%)

Closed February 17 3:00PM

Delayed by 15 minutes

2.08

0.00

(0.00%)

After Hours: 3:00PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

2.08

Bid

-

Ask

-

Volume

8,620

2.05 Day's Range 2.15

1.16 52 Week Range 3.25

Previous Close

2.15

Open

2.15

Last Trade

Last Trade Time

Average Volume (3m)

28,188

Financial Volume

US$ 18,079

VWAP

2.0973

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Impact BioMedical Inc. to Present at The Microcap Conference

HOUSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering...

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a...

Form 8-K - Current report

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering...

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.18	9.47368421053	1.9	2.39	1.87	26220	2.17988726	CS
4	0.39	23.0769230769	1.69	2.39	1.45	25256	1.89694791	CS
12	-0.37	-15.1020408163	2.45	2.95	1.16	28188	1.91144303	CS
26	-0.92	-30.6666666667	3	3.25	1.16	62123	2.20139729	CS
52	-0.92	-30.6666666667	3	3.25	1.16	62123	2.20139729	CS
156	-0.92	-30.6666666667	3	3.25	1.16	62123	2.20139729	CS
260	-0.92	-30.6666666667	3	3.25	1.16	62123	2.20139729	CS

IBO - Frequently Asked Questions (FAQ)

What is the current Impact Biomedical share price?

The current share price of Impact Biomedical is US$ 2.08

What is the 1 year trading range for Impact Biomedical share price?

Impact Biomedical has traded in the range of US$ 1.16 to US$ 3.25 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LFBBStone Ridge 2063 Longevity Income ETF	US$ 179.799 (900.00%)	4
LIBDStone Ridge 2065 Inflation Protected Longevity Income ETF	US$ 264.619 (900.00%)	2
LFDRStone Ridge Durable Income ETF	US$ 187.184 (900.00%)	3
LIAXStone Ridge 2063 Inflation-Protected Longevity Income ETF	US$ 264.897 (900.00%)	7
LFBEStone Ridge 2065 Longevity Income ETF	US$ 186.164 (900.00%)	3
HODLVanEck Bitcoin ETF	US$ 27.53 (-74.73%)	1.07M
ATCHAtlasClear Holdings Inc	US$ 2.65 (-19.70%)	490.18k
SCPXScorpius Holdings Inc	US$ 0.2798 (-17.71%)	1.75M
DXFEason Technology Limited	US$ 16.10 (-14.09%)	27.28k
YCBDcbdMD Inc	US$ 0.495 (-13.16%)	1.58M
FXIiShares China Large Cap	US$ 35.065 (2.65%)	61.58M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2.86 (0.18%)	55.31M
DNNDenison Mines Corp	US$ 1.63 (-6.86%)	53.11M
KWEBKraneShares CSI China Internet	US$ 35.65 (3.81%)	48.43M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 28.55 (0.28%)	43.36M

Disquisition

Disquisition 4 months ago

INCREDIBLE DUMPING

TrendTrade2016

TrendTrade2016 5 months ago

IBO...BOTTOM BOUNCER

rizah

rizah 2 years ago

All resolutions were approved by the required majority of shareholders at Universal Ibogaine Inc.'s (IBO)annual general meeting ("AGM"), which was held on October 3, 2022 in Vancouver, British Columbia. The company is a life sciences company with a mission to provide medicalized ibogaine-centered addiction care.

harry_brat

harry_brat 3 years ago

$IBO held on to its renowned capital market advisor

UI recently announced that it has retained Mr. Shayne Nyquvest as their capital market advisor in a consulting role. Mr. Nyquvest has substantial capital markets experience, having assisted companies in the mining, cannabis, and other growing industries with strategic fund-raising initiatives for over 4 decades.

Blue_Digital_Media

Blue_Digital_Media 3 years ago

Universal Ibogaine Inc. thanks to David for his contributions to the Company during his tenure as a Director.

Watch now IBO for latest stock information.

Impact Biomedical

Aquaron Acquisition

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions